Early detection, molecular mechanisms and therapeutic interventions in chronic kidney disease
ELIMINATE-CKD aims to enhance chronic kidney disease detection by developing a method to quantify nephron number using multi-omics and machine learning for improved diagnostics and therapies.
Projectdetails
Introduction
The objective of ELIMINATE-CKD is to demonstrate that combining measures of kidney structure and function will strongly enhance detection of chronic kidney disease (CKD). To reach this objective, I will develop a new method to quantify the number of nephrons, the smallest functional units in the kidney.
Rationale
- CKD affects ~10% of the global population and causes 2.6 million deaths/year. CKD-associated costs (140 billion euros/year in Europe) exceed diabetes and cancer. Limitations in CKD detection impede the success of emerging therapies.
- Current CKD definition is based on creatinine-based estimated glomerular filtration rate, which is often inaccurate due to interindividual differences in body composition and compensation for early kidney damage as remaining nephrons increase their function.
- Using a unique combination of multi-omics and machine learning approaches in human cohorts and innovative animal models, I will dissect pathways that drive nephron number and enable its quantification.
Concrete Objectives
- Develop a high-throughput method to quantify nephron number in large human cohorts and a novel rat model of gradual nephron reduction.
- Construct and validate unbiased and hypothesis-driven nephron number algorithms based on kidney-derived proteins, lipids, and metabolites in blood and urine.
- Demonstrate that nephron number algorithms enable earlier and more accurate CKD detection.
- Provide proof of principle that nephron number-triggered therapy prevents or halts CKD.
Impact
This project will lead to a new CKD classification, based on both structure and function. Identification of mechanisms driving nephron number will boost drug development and regenerative medicine towards nephron-preserving therapies. Finally, the concept of structure-function relationship is relevant in many other organs (brain, heart). My passion to beat kidney disease by innovative diagnostics drives me towards my ultimate goal: to eliminate CKD.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.000.000 |
Totale projectbegroting | € 2.000.000 |
Tijdlijn
Startdatum | 1-9-2024 |
Einddatum | 31-8-2029 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- ACADEMISCH ZIEKENHUIS GRONINGENpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Identification of novel diagnostic, predictive and therapeutic strategies in chronic kidney diseaseTargetCKD aims to revolutionize chronic kidney disease management by developing noninvasive diagnostics and novel therapeutics through advanced genomic technologies and interdisciplinary research. | ERC Consolid... | € 1.999.063 | 2022 | Details |
Deciphering the genetic basis of chronic kidney disease towards prevention and personalized therapyThis project aims to uncover the genetic basis of chronic kidney disease (CKD) through next-generation sequencing and develop RNA-based therapies for targeted treatment and improved management. | ERC Starting... | € 1.800.000 | 2022 | Details |
Improving Kidney Health by Targeting Urinary Biomarkers for Tubular FunctionU-Tube aims to identify urinary biomarkers for tubular function to enable early detection and treatment of progressive chronic kidney disease, improving patient outcomes. | ERC Consolid... | € 2.000.000 | 2024 | Details |
Decoding diabetic kidney diseaseDECODE-DKD aims to identify novel drug targets for diabetic kidney disease through patient-centric multi-omic research and in-vitro models, advancing precision medicine and treatment options. | ERC Starting... | € 1.783.319 | 2022 | Details |
Functional Measurements IN-THE-KIDNEY to Diagnose, Understand and Treat Renal TubulopathiesThis project aims to develop urine-based diagnostics and patient-specific models to enhance understanding and treatment of magnesium-wasting renal tubulopathies through innovative functional studies. | ERC Starting... | € 1.500.000 | 2022 | Details |
Identification of novel diagnostic, predictive and therapeutic strategies in chronic kidney disease
TargetCKD aims to revolutionize chronic kidney disease management by developing noninvasive diagnostics and novel therapeutics through advanced genomic technologies and interdisciplinary research.
Deciphering the genetic basis of chronic kidney disease towards prevention and personalized therapy
This project aims to uncover the genetic basis of chronic kidney disease (CKD) through next-generation sequencing and develop RNA-based therapies for targeted treatment and improved management.
Improving Kidney Health by Targeting Urinary Biomarkers for Tubular Function
U-Tube aims to identify urinary biomarkers for tubular function to enable early detection and treatment of progressive chronic kidney disease, improving patient outcomes.
Decoding diabetic kidney disease
DECODE-DKD aims to identify novel drug targets for diabetic kidney disease through patient-centric multi-omic research and in-vitro models, advancing precision medicine and treatment options.
Functional Measurements IN-THE-KIDNEY to Diagnose, Understand and Treat Renal Tubulopathies
This project aims to develop urine-based diagnostics and patient-specific models to enhance understanding and treatment of magnesium-wasting renal tubulopathies through innovative functional studies.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Ontwikkeling van een diagnostische test voor de vroege detectie van chronische nierschadeDit project onderzoekt de ontwikkeling van een niet-invasieve test voor de vroege detectie van chronische nierschade. | Mkb-innovati... | € 18.067 | 2024 | Details |
Kidney Disease Sweat sensor patch for Early diagnosis and Remote MonIToringThe KERMIT project aims to develop a cost-effective, disposable sweat patch for non-invasive early detection and remote monitoring of chronic kidney disease biomarkers. | EIC Pathfinder | € 3.080.623 | 2023 | Details |
breakthrough technologies for an implantable artificial kidneyKIDNEW aims to develop a modular implantable artificial kidney using innovative technologies for improved, cost-effective kidney replacement therapy without immunosuppressive drugs. | EIC Pathfinder | € 3.293.227 | 2023 | Details |
Haalbaarheid Renal Tracker+Het project onderzoekt de haalbaarheid van de Renal Tracker+, een serviceproduct dat nierpatiënten helpt om de impact van levensstijlveranderingen op hun ziekte te monitoren. | Mkb-innovati... | € 20.000 | 2020 | Details |
DETACT - Detection of Enzymes and muTAtions for Cancer TreatmentCytura Therapeutics en ENPICOM ontwikkelen een innovatieve diagnostische assay voor vroege kankerdetectie door het meten van enzymactiviteit en mutatiepatronen in bloedcellen. | Mkb-innovati... | € 215.845 | 2019 | Details |
Ontwikkeling van een diagnostische test voor de vroege detectie van chronische nierschade
Dit project onderzoekt de ontwikkeling van een niet-invasieve test voor de vroege detectie van chronische nierschade.
Kidney Disease Sweat sensor patch for Early diagnosis and Remote MonIToring
The KERMIT project aims to develop a cost-effective, disposable sweat patch for non-invasive early detection and remote monitoring of chronic kidney disease biomarkers.
breakthrough technologies for an implantable artificial kidney
KIDNEW aims to develop a modular implantable artificial kidney using innovative technologies for improved, cost-effective kidney replacement therapy without immunosuppressive drugs.
Haalbaarheid Renal Tracker+
Het project onderzoekt de haalbaarheid van de Renal Tracker+, een serviceproduct dat nierpatiënten helpt om de impact van levensstijlveranderingen op hun ziekte te monitoren.
DETACT - Detection of Enzymes and muTAtions for Cancer Treatment
Cytura Therapeutics en ENPICOM ontwikkelen een innovatieve diagnostische assay voor vroege kankerdetectie door het meten van enzymactiviteit en mutatiepatronen in bloedcellen.